New York, Feb. 14, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Hemostat Market size is forecasted to exceed USD 5.7 Billion by 2033, with a promising CAGR of 6.4% from 2024 to 2033 ...

Ax-Surgi Surgical Hemostat, a chitosan-based hemostat for controlling severe surgical bleeding, developed by Axio Biosolutions, has received the US Food and Drug Administration (FDA) 510(k) clearance.

Summary Topical Absorbable Hemostats (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Wound Care ...

SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may ...

For instance, in March 2020, Ethicon, a US-based provider of surgical sutures and wound closure devices, introduced a surgical powder absorbable hemostat, a powdered adjunctive hemostat that is built ...

The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...

At a symposium in Vienna, Austria, Baxter unveiled the new Hemopatch sealing hemostat, a room-temperature collagen pad designed for hemostasis and sealing in both open and minimally invasive ...

The FDA has approved a gene-based HIV assay (Aptima), a next-generation cochlear implant (Harmony HiResolution Bionic Ear System), and an absorbable surgical hemostat (Arista AH).

Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted ...

(MENAFN- GlobeNewsWire - Nasdaq) The development and adoption of advanced hemostatic agents and devices have been critical in propelling the market forward. Innovations in biotechnology and ...